IP Library Granted Patent US 9,597,435
Granted Patent B2
US 9,597,435 · App. 12/434,856 · Granted Mar 21, 2017

Medical devices having a bioresorbable coating layer with a pre-determined pattern for fragmentation

Inventors: Peter Edelman (Maple Grove, MN); Afsar Ali (Maple Grove, MN)
Assignee: BOSTON SCIENTIFIC SCIMED, INC.
A61L31/148A61L31/10A61L31/16A61L2300/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,597,435
App. No.
12/434,856
Granted
Mar 21, 2017
Kind
B2
Abstract

Intravascular medical devices comprising a coating layer disposed on a substrate associated with the medical device, wherein the coating layer has a pre-determined fragmentation pattern. At least a portion of the coating layer comprises a plurality of discontinuous bioresorbable members, wherein the discontinuous bioresorbable members have a size less than the luminal diameter of an arteriole. The coating layer may be formed by excavating portions of a coating layer (e.g., by laser ablation) to create gaps which define the discontinuous bioresorbable members. In certain embodiments, the coating layer is formed of a heat-bondable material. In such embodiments, the discontinuous bioresorbable members may be adhered to the substrate via heat bonds. Also disclosed are methods of forming a coating layer on medical devices and methods of treating intravascular sites.

Claims (36)

1. An intravascular medical device comprising:

a coating layer disposed on a substrate associated with the medical device;

wherein at least a portion of the coating layer comprises a plurality of discontinuous bioresorbable members that define a preferential pattern of fragmentation upon degradation of the coating layer, and wherein the discontinuous bioresorbable members have a size less than the luminal diameter of an arteriole.

2. The medical device of claim 1 , wherein the discontinuous bioresorbable members have a size less than 30 μm.

3. The medical device of claim 1 , wherein the discontinuous bioresorbable members have a size less than 10 μm.

4. The medical device of claim 1 , wherein the discontinuous bioresorbable members have a size approximately that of a red blood cell or smaller.

5. The medical device of claim 1 , wherein the substrate is another coating over a surface of the medical device.

6. The medical device of claim 1 , wherein the substrate is a surface of the medical device.

7. The medical device of claim 1 , wherein the coating layer comprises a polymer.

8. The medical device of claim 7 , wherein the polymer is a bioresorbable polymer.

9. The medical device of claim 1 , wherein the coating layer comprises a heat-bondable material.

10. The medical device of claim 9 , wherein the substrate comprises a heat-bondable material.

11. The medical device of claim 10 , wherein the substrate comprises a polymer.

12. The medical device of claim 9 , wherein at least some of the discontinuous bioresorbable members have heat-bonded portions at the interface of the discontinuous bioresorbable members and the substrate.

13. The medical device of claim 1 , wherein the substrate has a non-smooth surface.

14. The medical device of claim 13 , wherein at least some of the discontinuous bioresorbable members have interlocking portions that mechanically interlock with the non-smooth surface of the substrate.

15. The medical device of claim 1 , wherein the coating layer contains a therapeutic agent.

16. A method of forming a coating layer on a medical device, comprising:

disposing a coating layer on a substrate associated with the medical device; and

excavating portions of the coating layer to form a plurality of discontinuous bioresorbable members in the coating layer, wherein the discontinuous bioresorbable members define a preferential pattern of fragmentation upon degradation of the coating layer, and wherein the discontinuous bioresorbable members have a size less than the luminal diameter of an arteriole.

17. The method of claim 16 , wherein the discontinuous bioresorbable members have a size less than 30 μm.

18. The method of claim 16 , wherein the discontinuous bioresorbable members have a size less than 10 μm.

19. The method of claim 16 , wherein the discontinuous bioresorbable members have a size approximately that of a red blood cell or smaller.

20. The method of claim 16 , wherein the step of excavating is performed using an energetic beam.

21. The method of claim 20 , wherein the coating layer comprises a heat-bondable material, and wherein the step of excavating further comprises heating a localized area of the coating layer and/or substrate.

22. The method of claim 21 , wherein the step of heating the localized area results in the formation of heat bonds at the interface of the discontinuous bioresorbable members and the substrate.

23. A method of treating an intravascular site, comprising:

(a) providing a medical device comprising:

a coating layer disposed on a substrate associated with the medical device;

wherein at least a portion of the coating layer comprises a plurality of discontinuous bioresorbable members that define a preferential pattern of fragmentation upon degradation of the coating layer, and wherein the discontinuous bioresorbable members have a size less than the luminal diameter of an arteriole;

(b) delivering the medical device to the intravascular site.

24. The method of claim 23 , wherein the step of delivering the medical device further comprises implanting the medical device at the intravascular site.

25. The method of claim 23 , wherein the coating layer comprises a therapeutic agent.

26. The method of claim 23 , wherein the discontinuous bioresorbable members have a size less than 30 μm.

27. The method of claim 23 , wherein the discontinuous bioresorbable members have a size less than 10 μm.

28. The method of claim 23 , wherein the discontinuous bioresorbable members have a size approximately that of a red blood cell or smaller.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2009
From: EDELMAN, PETER; ALI, AFSAR
To: BOSTON SCIENTIFIC SCIMED, INC.
Reel/Frame 022632/0475 →
Continuity (2)
Provisional Application 61050449 · May 5, 2008
Related Publication 20090274743A1 · Nov 5, 2009